UPDATE 1-Sanofi-Regeneron drug has positive trial results in chronic sinusitis

September 30, 2014 6:50 AM

15 0

* Sanofi sees IL-4/IL-13 pathway as key in allergies (Adds detail, background)

PARIS, Sept 30 (Reuters) - An experimental drug from Sanofi and Regeneron significantly reduced congestion in a mid-stage trial on patients with chronic sinusitis with nasal polyps, a condition poorly controlled by existing drugs, the companies said on Tuesday.

Read more

To category page